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Purpose: The purpose of this study was to evaluate the visual acuity as well as endothelial 
cell density (ECD) and polymegathism after iris-fixated lens (Artiflex® AC 401) implantation 
for correction of moderate to high myopia.
Patients and methods: In this retrospective cross-sectional study, 55 eyes from 29 patients 
undergoing iris-fixated lens implantation for correction of myopia (−5.00 to −15.00 D) from 
2007 to 2014 were evaluated. Uncorrected visual acuity, best spectacle-corrected visual acuity, 
refraction, ECD and polymegathism (coefficient of variation [CV] in the sizes of endothelial 
cells) were measured preoperatively and 6 months postoperatively.
Results: In the sixth month of follow-up, the uncorrected vision acuity was 20/25 or better in 
81.5% of the eyes. The best-corrected visual acuity was 20/30 or better in 96.3% of the eyes, 
and more than 92% of the eyes had a refraction score of ±1 D from the target refraction. The 
mean corneal ECD of patients before surgery was 2,803±339 cells/mm2, which changed to 
2,744±369 cells/mm2 six months after surgery (p=0.142). CV in the sizes of endothelial cells before 
the surgery was 25.7%±7.1% and six months after surgery it was 25.9%±5.4% (p=0.857).
Conclusion: Artiflex iris-fixated lens implantation is a suitable and predictable method for 
correction of moderate to high myopia. There was no statistically significant change in ECD 
and polymegathism (CV in the sizes of endothelial cells) after 6 months of follow-up.
Keywords: cornea, endothelial cell, density, Artiflex, refractive surgery
Plain language summary
We studied the visual acuity as well as endothelial cell density (ECD) and polymegathism 
after Artiflex® iris-fixated lens implantation among patients with moderate to high myopia. Six 
months postoperatively, there was no statistically significant change in corneal ECD ( p=0.142) 
and also the coefficient of variation for endothelial cells’ size ( p=0.857). Our results indicate 
that Artiflex iris-fixated lens implantation is a suitable and predictable method for correction of 
moderate to high myopia, causing no statistically significant change in ECD and polymegathism 
after 6 months of follow-up.
Introduction
A variety of refractive surgeries are used to correct refractive errors among those 
who do not desire to use glasses or contact lenses. Since corneal methods have some 
limitations in correcting high myopia, phakic intraocular lens (IOL) implantation has 
been used to correct moderate and high myopia since 1986.1 However, one of the per-
ceived complications of phakic IOL is damage to corneal tissues, especially endothelial 
cells.2,3 Since endothelial cells in the human eye do not have the ability to reproduce, 
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any damage to these cells after infection, impact, surgical 
procedures and aging will affect their function.4,5
In various studies, it has been shown that endothelial 
cells naturally decrease with age.6,7 In addition, eye surgeries, 
especially intraocular surgeries, such as cataract surgery,8,9 
posterior chamber phakic IOL implantation,10,11 or iris-fixated 
IOL (iris claw lens),12,13 can reduce the density of these cells. 
Preoperative endothelial cell density (ECD) examination 
provides a good predictor of corneal condition after phakic 
IOL surgery.14
Many studies have indicated that iris-fixated IOL surgery 
is a predictable and effective method for correction of refrac-
tive errors.15,16 A study by Tehrani and Dick reported that 
ECD, 6 months after iris-fixated IOL implantation, had no 
significant difference with the preoperative readings.17 Pop 
and Payette18 reported that the reduction in endothelial cells 
was less than 1% at 6, 12 and 24 months after the surgery, 
which was not statistically significant. In addition, Tahzib 
et al19 reported that ECD did not show a significant reduction 
compared to preoperative readings in 1 month and 6 months 
as well as 10 years after the Artisan phakic IOL implanta-
tion. However, contrary to these studies, in 1997, Menezo 
et al20 reported that the reduction in ECD was 5.8% in the first 
6 months after the surgery and 7.9% after 12 months, which 
was statistically significant. In addition, in a study by Doors 
et al21 in 2008 with a mean follow-up of 34.1±24.7 months ECD 
was significantly reduced after iris-fixated IOL implantation, 
and in another study by Koss and Kohnen in 2009, a 10.5% 
reduc tion in endothelial cells was observed 22 months after 
secondary iris-claw IOL surgery in aphakic individuals.22
Therefore, regarding the different reports of changes 
in the count of endothelial cells after phakic IOL surgery, 
we decided to perform the present study to evaluate the 
changes in endothelial cells after Artiflex® iris-fixated lens 
implantation.
Patients and methods
In this retrospective study, 55 eyes of 29 patients referred to 
Vanak Ophthalmology Clinic, Tehran, Iran, from 2007 to 
2014 were evaluated. This study was approved by the ethics 
committee of Shahid Beheshti University of Medical Sciences 
and adhered to the rules established by the Declaration of Hel-
sinki. All participants gave a written and informed consent 
before their data were used in this study. The subjects had a 
myopic score ranging from −5.00 to −15.00 D, and their myo-
pic score was stable for 18 months prior to surgery (change of 
,0.5 D). In selecting the patients for Artiflex lens implanta-
tion, we followed the minimum requirements for ECD based 
on the recommendations by the manufacturer and patients’ 
age. All surgeries were performed by the same surgeon, and 
the same lens (Artiflex AC 401; Ophtec BV, Groningen, 
Nederland, overall diameter: 8.5 mm/body diameter: 6.0 mm, 
convex–concave/hydrophobic polysiloxane foldable design) 
was used in all eyes. Patients were asked to stop using soft 
contact lens 1 week and hard contact lens 3 weeks before the 
operation. In all patients, the anterior segment was normal 
and had no pathological defects. Anterior chamber angle in 
the Orbscan (Bausch & Lomb, Rochester, NY, USA) assess-
ment was $3.2 mm, and patients did not have any systemic 
or ocular pathology other than their refractive error.
Patient evaluation before and after 
the surgery
In all subjects, basic examinations, including best spectacle-
corrected visual acuity (BSCVA) and uncorrected visual 
acuity (UCVA), were performed using an auto chart projector 
(Nidek CP 670 [Nidek Co., Ltd.; Gamagori, Japan]). Manifest 
and cycloplegic refraction, the pupil size in scotopic light con-
dition (pupil size in scotopic condition should be less than lens 
optic zone), pachymetry (DGH Technology, Inc., Exton, PA, 
USA), topography, keratometry, precision examinations using 
slip lamp, tono meter applanation, indirect ophthalmoscopy 
and examination of endothelial cells were also performed.
endothelial cells’ evaluation
Corneal endothelial cells were studied in terms of cell density 
and cell size diversity (polymegathism) using specular 
microscopy (non-contact specular microscope: Topcon 
SP-3000P; Topcon Corp., Tokyo, Japan). All evaluations 
were performed by the same examiner, and three measure-
ments in each eye were taken. Finally, the mean of these three 
measurements was used in statistical analysis. Evaluation of 
endothelial cells was performed before and 6 months after 
the surgical procedure. The van der Heijde’s formula was 
used to calculate the IOL power.23
surgical method
An iridectomy was performed 2 days before surgery by a 
neodymium: YAG laser in all patients. All patients underwent 
general anesthesia. The dosage of the anesthetic agent was 
proportional and varied depending on the patient’s condi-
tion, including weight and drug sensitivity. The duration 
of anesthesia was between 20 and 60 minutes. To place the 
Artiflex foldable lens, a 3.2 mm clear corneal incision at the 
12 o’clock position was made and two stab incisions were 
also placed at 10 and 2 o’clock positions in the direction of the 
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enclavation sites. After injection of an ophthalmic cohesive 
viscosurgical substance (sodium hyaluronate 1%, Healon), 
the phakic intraocular lens was inserted into the anterior 
chamber using a specially designed implantation device 
for Artiflex lens (Operaid Artiflex Implantation Spatula; 
Ophtec BV). After positioning, the iris tissue was grasped 
and enclavated into the haptics at 3 and 9 o’clock with the aid 
of an Operaid Artiflex enclavation needle (Ophtec BV). The 
viscoelastic agent was removed by manual irrigation.
statistical methods
To present data, we used mean, SD, median and range and 
interquartile range. To assess the changes, we used paired 
t-test. All statistical analysis was performed using SPSS 
version 22.0 software (IBM Corporation, Armonk, NY, 
USA). p-values ,0.05 were considered as statistically 
significant. To have a power of 90% to detect 5% change 
of in the cell density when the SD of the changes was 
assumed to be 300 cells, a minimum sample size of 49 eyes 
was calculated.
Results
In total, 55 eyes from 29 patients with a refractive error 
of −5 to −15 D were included in the study. The average 
age of patients was 24.9 years with a range of 20–39 years. 
In all, 20 patients (75.9%) were female and seven patients 
(24.1%) were male. Uncorrected visual acuity (UCVA), 
best-corrected visual acuity (BCVA), spherical equivalent, 
corneal ECD and coefficient of variation (CV) in the sizes of 
endothelial cells before the surgery are shown in Table 1.
The ECD before lens implantation was 2,809±339 
cells/mm2, which changed to 2,744±369 cell/mm2 six months 
after surgery ( p=0.142; Table 2). The CV in the sizes of 
endothelial cells before surgery was 25.7%±7.1%, which 
changed to 25.9%±5.4% six months after surgery, showing 
no statistically significant change ( p=0.857; Table 2).
Discussion
In the present study, the visual acuity and changes in 
endothelial cells before and after Artiflex iris-fixated lens 
implantation were evaluated. The implantation of Artiflex 
lens is considered as an appropriate alternative to glasses 
and contact lens, especially in patients younger than 40 years 
with a high refractive error.
According to the results of examinations, 6 months 
after lens implantation, visual acuity in both eyes was sig-
nificantly improved, so that the mean BCVA before surgery 
was 0.11±0.23 LogMAR, which improved to 0.06±0.19 
LogMAR postoperatively ( p,0.001), and the mean UCVA 
before the surgery was 1.68±0.16 LogMAR, which improved 
to 0.10±0.22 LogMAR ( p,0.001). After the surgery, UCVA 
was 20/40 or better in 93% of the eyes, and BCVA was 20/30 
or better in 94% of the eyes. In a study by Akcay et al24 in 
2012, from 31 patients undergoing phakic anterior chamber 
lens implantation, 80% of the eyes showed improved BCVA 
18 months after the surgery. In a study by Dick et al25 in 
2009 on 191 patients receiving Artiflex phakic IOL, 37.7% 
of patients after 6 months and 41.8% of patients after 1 year 
of Artiflex implantation showed a BSCVA improvement of 
one line or better. In addition, in their study, 97.4% of the 
eyes after 6 months and 97.4% of the eyes after 1 year had a 
UCVA of .20/40.25 In another study by Yuan et al,26 among 
43 patients undergoing Artisan iris-fixated IOL implantation, 
79.7% of the eyes had a UCVA of 20/25 or better six months 
after surgery and 71.4% of the eyes had a BCVA improvement 
of one line or better 5 years after surgery.
In our study, 94% of the eyes had a refraction of ±1 D 
from target refraction within 6 months after the surgery. 
Similarly, Yuan et al26 reported that 93.2% of the eyes had 
a refraction of ±1 D from target refraction after 5 years of 
follow-up. In a study by Tahzib et al,19 74.2% of the eyes 
had refraction of ±1 D from target refraction after 1 year 
of Artisan phakic IOL implantation. Also in a study by 
Coullet et al,16 83.9% of the eyes had refraction of ±1 D 
from target refraction after 1 year of iris-supported phakic 
lens implantation.
According to our results, the ECD did not show a statisti-
cally significant change six months after refractive surgery 
Table 1 Demographic data of patients entering the study
Parameter Value
age (years) Mean ± sD 24.9±4.7
Median (range) 23 (20–39)
sex, n (%) Females 22 (75.9)
Males 7 (24.1)
UCVa (before surgery) Mean ± sD 1.68±0.16
Median (range) 1.6 (1.4–1.9)
BCVa (before surgery) Mean ± sD 0.11±0.23
Median (range) 0.04 (0–1.3)
se (before surgery) Mean ± sD −9.13±2.49
Median (range) −8.62 (−15 to −0.87)
eCD (before surgery) Mean ± sD 2,803±339
Median (range) 2,776 (2,032–3,697)
CV in the sizes of endothelial 
cells (before surgery)
Mean ± sD
Median (range)
25.7±7.1
24 (13–49)
Abbreviations: UCVa, uncorrected visual acuity; BCVa, best-corrected visual 
acuity; SE, spherical equivalent; ECD, endothelial cell density; CV, coefficient of 
variation.
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compared to baseline count. Similar to our findings Dick 
et al25 reported no statistically significant changes in the 
density of endothelial cells 6 months, 1 year and 2 years 
after Artiflex lens implantation and contributed this to lack 
of direct contact between the endothelial cells and lens sur-
face. In addition, Tahzib et al19 did not observe a statistically 
significant reduction in the endothelial cell count 1 month, 
6 months and 10 years after Artisan phakic IOL implantation 
for the correction of moderate to high myopia. In another 
study by Pop and Payette,18 the reduction in the endothelial 
cell count in Artisan lens implantation was ,1% in 6, 12 
and 24 months after the surgery, which was not statistically 
significant.
Our findings are however in contrast with the find-
ings of Akcay et al,24 who evaluated ECD 1 month and 
18 months after phakic anterior chamber lens implantation 
to correct very high myopia and reported an 8.61% reduc-
tion 18 months postoperatively, which was statistically 
significant. Also in a study by Menezo et al20 in 1997, 
which evaluated ECD in 6-month intervals for 5 years, the 
cell density reduction after iris claw phakic IOL implanta-
tion for correction of high myopia was ~5.8% in the first 
6 months and 7.9% after 12 months, which was statistically 
significant. In this study, Worst–Fechner iris claw lens 
with biconcave or concave–convex design was used and 
some factors such as surgical technique, lens position, lens 
design, lens material and viscoelastic materials used during 
surgery had a relation with endothelial cell damage.20 In a 
study by Budo et al13 in year 2000, ECD after Artisan lens 
implantation was reduced by 4.8% in 6 months and 2.4% 
in 1 year after the surgery. Benedetti et al12 also evaluated 
ECD after Artisan lens implantation and reported a cell loss 
of 2.3% after 4 months and 3.5% after 12 months, which 
was statistically significant. It should be noted that in the 
last three abovementioned studies reporting a significant 
endothelial cell loss, the surgical incision was ~5.5 to 6.5 mm, 
which is more likely to increase the corneal manipulation 
and surgical trauma compared with Artiflex lens implanta-
tion, with an incision of ~3.2 mm. In addition, the mean age 
of subjects in all three studies was higher than the average 
age of our patients, which might explain part of the differ-
ence in reported endothelial cell loss. It should also be noted 
that although the mean percentage of decrease in ECD at 
6 months in the present study was only 2.1% and not statisti-
cally significant, with a longer follow-up, this may become 
statistically significant compared to the normal age-related 
decline.
In the present study, the CV in the sizes of endothelial 
cells (polymegathism) before the surgery was 25.7%±7.1%, 
which changed to 25.9%±5.4% 6 months postoperatively, 
showing no statistically significant change ( p=0.857; 
Table 2). Similarly in 2007, Benedetti et al12 did not find a 
significant change in the CV in the sizes of endothelial cells 
5 years after Artisan lens implantation. In addition, Menezo 
et al20 found no significant change in the CV after iris claw 
phakic IOL implantation for correction of high myopia.
Some limitations of the present study were the retrospec-
tive nature of the study, a relatively low number of partici-
pants and a short period of follow-up.
Conclusion
Artiflex iris-fixated lens implantation is a suitable and pre-
dictable method for correction of moderate to high myopia. 
There was no statistically significant change in cell density 
and CV in the sizes of endothelial cells after 6 months of 
follow-up.
Disclosure
The authors report no conflicts of interest in this work.
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